These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15340574

  • 21. A PCR-RFLP based protocol for the detection of hepatitis B virus variants in some lamivudine-untreated chronic hepatitis B virus carriers in Pakistan.
    Tauseef I, Iqbal F, Rehman W, Ali M, Qureshi JA, Aslam MA.
    Pak J Pharm Sci; 2012 Apr; 25(2):349-52. PubMed ID: 22459460
    [Abstract] [Full Text] [Related]

  • 22. Detection of hepatitis B virus polymerase variations resistant to lamivudine therapy.
    Zhang X, Han Y, Lu Z, Zhang D, Cai Y.
    Chin Med J (Engl); 2000 May; 113(5):455-7. PubMed ID: 11776105
    [Abstract] [Full Text] [Related]

  • 23. Identification of HBV DNA sequences that are predictive of response to lamivudine therapy.
    Ciancio A, Smedile A, Rizzetto M, Lagget M, Gerin J, Korba B.
    Hepatology; 2004 Jan; 39(1):64-73. PubMed ID: 14752824
    [Abstract] [Full Text] [Related]

  • 24. Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.
    Kim JK, Lee HJ, Lee YJ, Chun JY, Lee IK, Lim YS, Suh DJ, Ko SY, Kim MH, Oh HB.
    J Virol Methods; 2008 Apr; 149(1):76-84. PubMed ID: 18291537
    [Abstract] [Full Text] [Related]

  • 25. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.
    Amini-Bavil-Olyaee S, Hosseini SY, Sabahi F, Alavian SM.
    Int J Infect Dis; 2008 Jan; 12(1):83-7. PubMed ID: 17698384
    [Abstract] [Full Text] [Related]

  • 26. Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase.
    Fukai K, Zhang KY, Imazeki F, Kurihara T, Mikata R, Yokosuka O.
    J Viral Hepat; 2007 Sep; 14(9):661-6. PubMed ID: 17697019
    [Abstract] [Full Text] [Related]

  • 27. Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy.
    Hacker HJ, Zhang W, Tokus M, Bock T, Schröder CH.
    Ann N Y Acad Sci; 2004 Jun; 1022():271-81. PubMed ID: 15251972
    [Abstract] [Full Text] [Related]

  • 28. [Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].
    Shin YM, Heo J, Kim GH, Kang DH, Song GA, Cho M, Yang US, Kim CM, Park HK, Jang HJ.
    Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):1-9. PubMed ID: 12657823
    [Abstract] [Full Text] [Related]

  • 29. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B.
    Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, Piselli P, Puro V, Capobianchi MR, Antonucci G.
    J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624
    [Abstract] [Full Text] [Related]

  • 30. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, Mphahlele MJ.
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [Abstract] [Full Text] [Related]

  • 31. Quantitation of hepatitis B lamivudine resistant mutants by real-time amplification refractory mutation system PCR.
    Punia P, Cane P, Teo CG, Saunders N.
    J Hepatol; 2004 Jun; 40(6):986-92. PubMed ID: 15158340
    [Abstract] [Full Text] [Related]

  • 32. [Mutation patterns in the RT region of hepatitis B virus P gene in patients treated with nucleoside/nucleotide analogs].
    DENG J, ZHANG DH, YU DM, CHEN L, ZHANG XX.
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):342-5. PubMed ID: 19497198
    [Abstract] [Full Text] [Related]

  • 33. Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.
    Ramezani A, Velayati AA, Roshan MR, Gachkar L, Banifazl M, Keyvani H, Aghakhani A.
    Int J Infect Dis; 2008 May; 12(3):252-5. PubMed ID: 17954033
    [Abstract] [Full Text] [Related]

  • 34. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF.
    J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
    [Abstract] [Full Text] [Related]

  • 35. [Analysis of three lamivudine-resistant HBV mutants with the method of restriction enzyme digestion and its application].
    Sun J, Hou JL, Xiao L, Wang ZH, Zhang L, Luo KX.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):18-20. PubMed ID: 12870011
    [Abstract] [Full Text] [Related]

  • 36. Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine.
    Matsuda M, Suzuki F, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Satoh J, Takagi K, Kobayashi M, Ikeda K, Kumada H.
    J Gastroenterol; 2004 Jan; 39(1):34-40. PubMed ID: 14767732
    [Abstract] [Full Text] [Related]

  • 37. [Predictive factors of hepatitis B virus DNA negative conversion among patients with chronic hepatitis B during lamivudine therapy].
    Chen JL, Wang L, Yan J, Zhang L, Yu H, Fan XL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):273-5. PubMed ID: 17971944
    [Abstract] [Full Text] [Related]

  • 38. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.
    Pollicino T, Isgrò G, Di Stefano R, Ferraro D, Maimone S, Brancatelli S, Squadrito G, Di Marco V, Craxì A, Raimondo G.
    Antivir Ther; 2009 Sep; 14(5):649-54. PubMed ID: 19704167
    [Abstract] [Full Text] [Related]

  • 39. Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B.
    Chen JY, Wang LW, Sun XM, Gong ZJ.
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):393-7. PubMed ID: 16109523
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.
    Kim HS, Han KH, Ahn SH, Kim EO, Chang HY, Moon MS, Chung HJ, Yoo W, Kim SO, Hong SP.
    Antivir Ther; 2005 Aug; 10(3):441-9. PubMed ID: 15918335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.